Senior Director Global Clinical Development @BioNTech_Group, Medical Oncologist,Physician-scientist, Past VHIO IRSI #immunotherapy#precisionmedicine ViewsMine
🔬Excited to share our research @NatureComms! We shed light on the complex interaction between evolving #TNBC and the immune system, highlighting its dynamic nature.
https://t.co/9sgV4fsbOq
Key findings👇
Views are my own
#cancerresearch#breastcancer@OncoAlert@IrsiCaixa
🔬Excited to share our research @NatureComms! We shed light on the complex interaction between evolving #TNBC and the immune system, highlighting its dynamic nature.
https://t.co/9sgV4fsbOq
Key findings👇
Views are my own
#cancerresearch#breastcancer@OncoAlert@IrsiCaixa
THE most complete T cell repertoire of a single breast cancer patient!
1 Primary tumor, 15 biopsies on treatment, 18 blood samples, 2 body fluids and 20 metastases at autopsy.
Great collaboration @OmniscopeAI@cnag_eu led by @demattosarruda@IrsiCaixa
https://t.co/TGELrWfAWR
The "one-size-fits-all" approach falls short. Our findings open doors for:
· More precise & effective combinatory therapies
· Targeting both cancer & immune system vulnerabilities
#personalizedmedicine#futureofcancer#jointheresearch
🔬Excited to share our research @NatureComms! We shed light on the complex interaction between evolving #TNBC and the immune system, highlighting its dynamic nature.
https://t.co/9sgV4fsbOq
Key findings👇
Views are my own
#cancerresearch#breastcancer@OncoAlert@IrsiCaixa
We developed novel methods to track the dynamic interaction:
· TCR repertoire & its evolution
· Immunophenotype & T cell exhaustion
· #Neoantigen emergence ("Neoantigen Time")⏰
· Liquid biopsy based on immune markers (PD-L1, IFNy) 💉
More👇
#immunotherapy#science#liquidbiopsy
Proud to have contributed to this paper during my academia time! Huge congrats to the teams for showcasing a novel neoantigen selection pipeline & potential for #cancerimmunotherapy using engineered HIV-1 Gag-based VLPs. #cancer@IrsiCaixa
Views Mine
https://t.co/jRtQQF0oGO
Driven by scientific rigor & deeply rooted in academia, passing on our knowledge is part of our legacy. We've started an intl. PhD program with @tronmainz, focusing on translational medicine. Interested? The application deadline is January 15th, 2023. https://t.co/L9GdpdbX6Y
Save your spot for the next #YOC virtual mentorship with Emiliano Calvo, director of Start Madrid group
⏱ Mo 12 July 18:00-19:00 CEST
We will discuss the application of #AI in Gastrointestinal malignancies and #PrecisionOncology@myESMO
👇🏼
https://t.co/Ev1HBsV4iK
Shout out to @myESMO for a fantastic Communications Training included in the ESMO Leaders Generation Programme last weekend. So much food for thoughts on the importance of good science communication. I feel like I'm ready for an interview with @AndrewMarr9#LGP#oneoncology
Shout out to @myESMO for a fantastic Communications Training included in the ESMO Leaders Generation Programme last weekend. So much food for thoughts on the importance of good science communication. I feel like I'm ready for an interview with @AndrewMarr9#LGP#oneoncology